How Much Does Trulicity Cost in Wyoming in 2026?

Wyoming Retail Pricing for Trulicity in 2026

The average cash-pay price for brand-name Trulicity at Wyoming retail pharmacies is $931 per month in 2026, matching Eli Lilly's national list price. That figure covers a pack of four single-dose pens (one injection per week). Prices at individual pharmacies vary by only a few dollars at best, because Trulicity has no FDA-approved generic equivalent and Eli Lilly sets the wholesale acquisition cost (WAC) nationally.

Wyoming's small population (roughly 577,000) means the state has fewer retail pharmacy locations competing on price, which limits the kind of cash-pay discounting seen in larger markets. Patients paying out of pocket in Cheyenne, Casper, or Gillette will find prices clustered tightly around the WAC. GoodRx-style discount cards may reduce the cost to the $830 to $880 range at select chains, but these savings are modest relative to the sticker price.

Dulaglutide received FDA approval in 2014 as a once-weekly GLP-1 receptor agonist for glycemic control in adults with type 2 diabetes 1. The REWIND trial (N=9,901) later demonstrated a 12% reduction in major adverse cardiovascular events (MACE) with dulaglutide 1.5 mg versus placebo over a median 5.4-year follow-up (HR 0.88, 95% CI 0.79 to 0.99) 2. That cardiovascular benefit earned Trulicity an expanded FDA indication and placed it on the American Diabetes Association's Standards of Care as a preferred agent for patients with type 2 diabetes and established or high-risk atherosclerotic cardiovascular disease 3.

Wyoming Medicaid Does Not Cover Trulicity

Wyoming Medicaid does not include Trulicity on its preferred drug list for type 2 diabetes. This is a significant barrier. Wyoming has one of the nation's most restrictive Medicaid formularies for GLP-1 receptor agonists, and prior authorization requests for Trulicity are routinely denied unless the patient has documented failure on at least two preferred agents (typically metformin and a sulfonylurea).

For the approximately 70,000 Wyoming residents enrolled in Medicaid, the practical effect is that out-of-pocket costs for Trulicity approach the full list price of $931 per month. The ADA's 2024 Standards of Care recommend GLP-1 receptor agonists as second-line therapy after metformin for patients with established cardiovascular disease 3, yet formulary restrictions in states like Wyoming create a gap between guideline recommendations and actual patient access.

Patients denied Medicaid coverage have three options: appeal the denial with supporting clinical documentation from their prescriber, switch to a Medicaid-preferred GLP-1 agonist if one exists on the state formulary, or pursue manufacturer assistance programs directly through Eli Lilly.

Commercial Insurance Coverage in Wyoming

Most commercial insurance plans sold on Wyoming's ACA marketplace or through employer-sponsored coverage do include Trulicity, though tier placement and copay amounts vary. Plans from Blue Cross Blue Shield of Wyoming and UnitedHealthcare (the two largest carriers in the state) generally place Trulicity on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), resulting in copays between $50 and $150 per month after deductible.

Some high-deductible health plans require patients to pay the full $931 until the annual deductible is met. That front-loaded cost catches many patients off guard in January and February.

Step therapy is common. A 2023 analysis of commercial formularies found that 68% of plans required documented metformin use before approving a GLP-1 receptor agonist 4. Wyoming plans follow this pattern. Patients should expect their insurer to require a prior authorization confirming at least one failed oral agent before covering Trulicity.

The fastest way to confirm your plan's coverage is to call the number on the back of your insurance card and ask for the pharmacy benefit tier for dulaglutide. Request the formulary exception criteria in writing so your prescriber can submit targeted documentation if the initial prior authorization is denied.

The Eli Lilly Savings Card: How It Works in Wyoming

Eli Lilly's Trulicity Savings Card is available to commercially insured patients in Wyoming. The card reduces out-of-pocket costs to as little as $25 per monthly fill, with a maximum annual benefit of $6,000 5. Here are the key eligibility rules.

The patient must have commercial (private) insurance. Medicare, Medicaid, Tricare, and other government-funded programs are excluded by federal anti-kickback statute. The savings card applies at the point of sale: the pharmacist runs the patient's primary insurance first, then applies the Lilly card as a secondary discount. If the insurer's copay is $150, the savings card covers up to $125 of that, bringing the patient's cost to $25.

Patients with no insurance do not qualify for the standard savings card but may qualify for the Lilly Cares Foundation, a separate patient assistance program that provides Trulicity at no cost to qualifying individuals with household incomes below 400% of the federal poverty level. For a single person in Wyoming, that threshold is approximately $62,400 in 2026.

Activation requires a valid prescription and a brief online enrollment at the manufacturer's website. The card auto-renews annually unless Lilly modifies the program terms. Several Wyoming patients have reported that independent pharmacies in Sheridan and Jackson process the card more quickly than chain locations, though this is anecdotal.

Compounded Dulaglutide: Legal Status in Wyoming

Compounded dulaglutide is available in Wyoming through 503A compounding pharmacies. A 503A pharmacy operates under a patient-specific prescription, meaning a licensed prescriber must write an individual order for each patient. This is legal under both federal law (section 503A of the Federal Food, Drug, and Cosmetic Act) and Wyoming Board of Pharmacy regulations 6.

The distinction matters. 503B outsourcing facilities produce compounded drugs in bulk without patient-specific prescriptions, and dulaglutide compounding under the 503B pathway faces more regulatory scrutiny because the branded product (Trulicity) remains on the market and is not on the FDA drug shortage list.

Pricing for compounded dulaglutide varies by pharmacy but is typically dramatically lower than the brand-name product. Some 503A pharmacies advertise compounded GLP-1 agonists for as little as $150 to $350 per month, though dulaglutide-specific pricing depends on sourcing of the active pharmaceutical ingredient (API) and the compounding pharmacy's margin.

Patients considering compounded dulaglutide should confirm three things: the pharmacy holds a valid Wyoming Board of Pharmacy license, the API is sourced from an FDA-registered supplier, and their prescriber is willing to write the compounding-specific prescription. The compounded product will not be in Trulicity's proprietary auto-injector pen; it typically comes as a vial requiring manual syringe injection.

Telehealth Prescribing of Trulicity in Wyoming

Wyoming permits telehealth prescribing of Trulicity with no in-person visit requirement. The Wyoming Telehealth Act, updated in 2023, allows licensed prescribers to establish a patient-provider relationship via synchronous audio-video consultation and prescribe schedule-unscheduled medications including GLP-1 receptor agonists 7.

This is particularly relevant for rural Wyoming. Roughly 97% of the state's land area is classified as rural by the U.S. Census Bureau, and many residents live more than 60 miles from an endocrinologist. Telehealth eliminates that barrier.

The AWARD-11 trial demonstrated that dulaglutide at higher doses (3.0 mg and 4.5 mg weekly) provided greater HbA1c reductions than the 1.5 mg dose (mean difference of -0.24% for 3.0 mg and -0.40% for 4.5 mg vs. 1.5 mg at 36 weeks, P<0.001 for both comparisons) 8. Telehealth-based dose titration allows prescribers to move patients from 0.75 mg to higher doses over 8 to 16 weeks while monitoring for gastrointestinal side effects remotely.

HealthRX offers telehealth consultations for GLP-1 therapy in Wyoming with board-certified providers who can evaluate candidacy, prescribe, and manage ongoing titration without requiring an office visit.

How to Minimize Your Trulicity Cost in Wyoming

A step-by-step approach to reducing what you actually pay.

Step 1: Check your formulary. Call your insurer's pharmacy benefit line. Ask whether dulaglutide is Tier 2, 3, or 4, and whether prior authorization is required. Get the PA criteria in writing.

Step 2: Apply for the Lilly Savings Card. If you have commercial insurance, enroll before your first fill. The card stacks on top of your insurance benefit and can cut your copay to $25.

Step 3: Ask about Lilly Cares. If you are uninsured or underinsured with household income below 400% FPL, apply for the patient assistance program for no-cost Trulicity.

Step 4: Evaluate compounded dulaglutide. If cost remains prohibitive, discuss compounded dulaglutide with your prescriber. A licensed Wyoming 503A pharmacy can fill a patient-specific prescription at a fraction of the brand price.

Step 5: Consider therapeutic alternatives. Semaglutide (Ozempic) and tirzepatide (Mounjaro) are in the same drug class. Your insurer may prefer one over the other. The SUSTAIN-7 trial (N=1,201) showed semaglutide 1.0 mg produced a -1.4% HbA1c reduction versus -1.1% for dulaglutide 1.5 mg at 40 weeks 9. If your insurer covers semaglutide at a lower tier, switching may be clinically reasonable and financially beneficial.

Step 6: Use a telehealth provider. Avoid the cost and travel time of repeated in-person visits. Wyoming law permits full telehealth management of GLP-1 therapy.

Dulaglutide Dosing and What to Expect Clinically

Trulicity is injected once weekly, on the same day each week, at any time of day, with or without food. The starting dose is 0.75 mg weekly for at least four weeks, then 1.5 mg weekly. Doses of 3.0 mg and 4.5 mg are available for patients needing additional glycemic control 1.

The most common side effects are gastrointestinal: nausea (12.4%), diarrhea (8.9%), and vomiting (6.0%) based on pooled AWARD trial data 10. These effects are dose-dependent and typically diminish after 4 to 8 weeks. Slow titration reduces their severity.

In the REWIND trial, dulaglutide 1.5 mg also produced modest weight loss (mean 2.95 kg more than placebo at trial end) in a population that was 31% non-diabetic at baseline 2. The cardiovascular benefit was observed across subgroups including patients aged 50 and older with prior cardiovascular events and those with cardiovascular risk factors alone.

Dr. Hertzel Gerstein, principal investigator of REWIND, noted: "The cardiovascular benefit of dulaglutide was consistent regardless of whether patients had prior cardiovascular disease, making it broadly applicable to the type 2 diabetes population at elevated risk" 2.

The Endocrine Society's 2023 clinical practice guideline states: "GLP-1 receptor agonists should be prioritized over other injectable therapies for patients with type 2 diabetes and atherosclerotic cardiovascular disease" 11.

Wyoming-Specific Access Considerations

Wyoming's regulatory environment is permissive for both telehealth and 503A compounding, which creates more access pathways than many neighboring states. Montana and South Dakota have more restrictive telehealth prescribing rules for injectable medications. Idaho limits 503A compounding more narrowly.

The challenge specific to Wyoming is the Medicaid gap. With no Trulicity coverage on the state Medicaid formulary and a relatively high uninsured rate (approximately 11.5% of the non-elderly population per KFF data), a significant portion of Wyoming residents with type 2 diabetes face the full $931 monthly cost without a clear reimbursement pathway.

Patients in this situation should prioritize the Lilly Cares application, then explore whether compounded dulaglutide from a Wyoming-licensed 503A pharmacy meets their clinical needs. A board-certified provider can help determine whether the compounded formulation is appropriate based on the patient's dose requirements and injection comfort level.

Trulicity pens should be stored refrigerated (36 to 46°F) until use; a single pen may be kept at room temperature (up to 86°F) for up to 14 days 1. Wyoming's climate extremes make this relevant: pens left in a vehicle during a Cheyenne winter or a Thermopolis summer will fall outside the acceptable range and should be discarded.